Midday Wave #111: Breadth Says Buy, Volume Says Wait – Thursday 9/17/2026

Welcome to Wave Rider Midday Wave, your mid-session market intelligence. Let's dive in. Bowl momentum count doubled since the open, 160 to 295. But if I told you almost none of today's leading stocks are moving on real volume, would you still chase it? I mean, that's the whole tension right there. Yeah, honestly. Okay, so how has the regime actually shifted since this morning? So breadth is expanding. The 40 SMA ticked up to 28.83% from 28.38%. Barely. Barely, right. Still a visually neutral. But the 20 SMA jumped harder, 25% to 28%. So short-term participation is moving faster. You know what, much faster. Right. And the 4% flip is the headline. Bowl 4% surged from 160 to 295. Bare 4% collapsed from 234 to 37. Whoa, in one day? One day, decisive reversal. Oh wow. Is that broad base, though? Here's the thing. Well, that's the catch. Index levels for SPY, QQQ, and the small caps are dark today. So I'm leaning entirely on breadth and single names. Hmm. Hmm. So the tape looks like a crowd rushing back in, but the building's structural rating hasn't been upgraded. Exactly that. Yeah, totally. Okay, so participation's expanding, but is it showing up in the stocks actually leading? And like here's where it gets interesting. The moves are real. The volume isn't. Mm-hmm. Give me examples. So basically, mRNA. Up 7.2% to $156.5. That's a big move. Big move. Arval of .3. Right. .3? That's nothing. It's a firework and daylight. You see it, but didn't make a sound. Right. Exactly. Then UI up 4.1% to $593.91. Arval .2. And FSLY up 4.7% to $2464. Arval .4. So grinding higher, not exploding. Grinding. Nobody's really behind these. Sure. And the new stocks in play are they behaving like they're catalysts? Look. No. And that's the tell. NOK landed an expanded automation partnership head. Good news. Great news. Down 2.5% from the open. Oh, man. Huh. And DIA got flagged bullish on an oil retreat rally. Arval .1.79, yet it's down 1.29% from open. So narrative and price are just diverging. Five-star review, empty theater. Right. So is anything confirming? Honestly, two names. TTRX. Up 3.2% to $14.16. Arval .2.3. 33.3% risk in the 20% study. There's the volume. Cleanest setup on the board. Yeah. And EICN at $8.51. Arval .2.13. The lone individual stock in that scan with real backing. Alongside CRCA and LABX sitting at demand. So on the whole board, only those pair are real move with real. With real volume? Only those. Exactly. OK, that's the thing that matters. Breath says buy. Volume says be picky. So what changes for the afternoon? I mean, tighter risk mostly. The buy stays cautiously constructive. 295 bull versus 37 bear favors lungs on paper. OK. On paper. Right. But with Arval this week across the leaders, you go selective. First 5 minutes entries only. Got it. And the level that matters most? You know, TTRX $14.16. Hold above it with that Arval .2.3 and the continuation setup stays intact into the clothes. Mm-hmm. An mRNA? mRNA 156.5 cents is your line in the sand. It needs afternoon volume or... Or you fade it. Or you treat it as suspect, prone to fading. Exactly. So today's less about trusting every green candle. And more about asking which ones have real people behind them. I like that. So the takeaway. Breath has turned bullish, but conviction. Hasn't. Trade the names with volume, not just the color. Right. Watch TTRX $14.16 and mRNA 156.5 cents into the clothes. Keep your risk tight until the volume actually confirms. That's the Midday Wave. We'll catch you on the next one. That's all for today's episode of Wave Rider Midday Wave. Your mid-session market intelligence. See you next time.